To determine whether AF1q is a potential survival-related gene for CML leukemia stem cells, we measured its expression in CD34+ progenitor cells from newly diagnosed CP CML patients. The gene discussed is CD34; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.